87.74
[1]. Rickert P, et al. Cyclin C/CDK8 and cyclin H/CDK7/p are biochemically distinct CTD kinases. Oncogene. 1999 Jan 8;18(4):109-10.
[]. Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother. 00 Dec;50():779-9.
[]. te Poele RH, et al. RNA synthesis block by 5, -dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p5-dependent apoptosis in human colon carcinoma cells. Oncogene. 1999 Oct 14;18(4):575-7.
[4]. Yankulov K, et al. The transcriptional elongation inhibitor 5,-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem. 1995 Oct 1;70(41):9-5.
[5]. Zandomeni RO. Kinetics of inhibition by 5,-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem J. 1989 Sep 1;():49-7.
H0-H15-H19-H5
P1-P4-P70-P71-P80-P0+P5-P04+P40-P05+P51+P8-P0-P+P4-P40+P-P405-P501